The pharmaceutical company rode one copycat drug to record profits. Now, co-chairman G.V. Prasad has to prove the company can grow without it. Biosimilars and innovation may hold the answer.
#lottery #win #Reddys #laboratories
After the lottery win: why Dr Reddy’s may be doing much more in its laboratories
